UniProt ID | ATG4C_HUMAN | |
---|---|---|
UniProt AC | Q96DT6 | |
Protein Name | Cysteine protease ATG4C | |
Gene Name | ATG4C | |
Organism | Homo sapiens (Human). | |
Sequence Length | 458 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Cysteine protease required for the cytoplasm to vacuole transport (Cvt) and autophagy. Is not essential for autophagy development under normal conditions but is required for a proper autophagic response under stressful conditions such as prolonged starvation (By similarity). Cleaves the C-terminal amino acid of ATG8 family proteins MAP1LC3 and GABARAPL2, to reveal a C-terminal glycine. Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy. Has also an activity of delipidating enzyme for the PE-conjugated forms.. | |
Protein Sequence | MEATGTDEVDKLKTKFISAWNNMKYSWVLKTKTYFSRNSPVLLLGKCYHFKYEDEDKTLPAESGCTIEDHVIAGNVEEFRKDFISRIWLTYREEFPQIEGSALTTDCGWGCTLRTGQMLLAQGLILHFLGRAWTWPDALNIENSDSESWTSHTVKKFTASFEASLSGEREFKTPTISLKETIGKYSDDHEMRNEVYHRKIISWFGDSPLALFGLHQLIEYGKKSGKKAGDWYGPAVVAHILRKAVEEARHPDLQGITIYVAQDCTVYNSDVIDKQSASMTSDNADDKAVIILVPVRLGGERTNTDYLEFVKGILSLEYCVGIIGGKPKQSYYFAGFQDDSLIYMDPHYCQSFVDVSIKDFPLETFHCPSPKKMSFRKMDPSCTIGFYCRNVQDFKRASEEITKMLKFSSKEKYPLFTFVNGHSRDYDFTSTTTNEEDLFSEDEKKQLKRFSTEEFVLL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEATGTDE -------CCCCCCHH | 7.74 | 19413330 | |
11 | Ubiquitination | TGTDEVDKLKTKFIS CCCHHHHHHHHHHHH | 57.99 | - | |
11 | Acetylation | TGTDEVDKLKTKFIS CCCHHHHHHHHHHHH | 57.99 | 25953088 | |
15 | Ubiquitination | EVDKLKTKFISAWNN HHHHHHHHHHHHHHC | 38.83 | - | |
18 | Phosphorylation | KLKTKFISAWNNMKY HHHHHHHHHHHCCCE | 30.29 | - | |
25 | Phosphorylation | SAWNNMKYSWVLKTK HHHHCCCEEEEEECC | 9.30 | 25072903 | |
26 | Phosphorylation | AWNNMKYSWVLKTKT HHHCCCEEEEEECCC | 12.75 | 25072903 | |
31 | Phosphorylation | KYSWVLKTKTYFSRN CEEEEEECCCCCCCC | 25.18 | 25072903 | |
33 | Phosphorylation | SWVLKTKTYFSRNSP EEEEECCCCCCCCCC | 34.72 | 25072903 | |
34 | Phosphorylation | WVLKTKTYFSRNSPV EEEECCCCCCCCCCE | 10.91 | 25072903 | |
36 | Phosphorylation | LKTKTYFSRNSPVLL EECCCCCCCCCCEEE | 21.82 | 25072903 | |
144 | Phosphorylation | DALNIENSDSESWTS CCCCCCCCCCCCCCC | 29.71 | 28348404 | |
158 | Phosphorylation | SHTVKKFTASFEASL CCEEEEEEEEEEHHH | 30.21 | 24719451 | |
160 | Phosphorylation | TVKKFTASFEASLSG EEEEEEEEEEHHHCC | 22.14 | 26471730 | |
164 | Phosphorylation | FTASFEASLSGEREF EEEEEEHHHCCCCCC | 18.83 | 24719451 | |
166 | Phosphorylation | ASFEASLSGEREFKT EEEEHHHCCCCCCCC | 35.79 | 24719451 | |
173 | Phosphorylation | SGEREFKTPTISLKE CCCCCCCCCEEEHHH | 30.87 | 28555341 | |
179 | Ubiquitination | KTPTISLKETIGKYS CCCEEEHHHHHHCCC | 46.12 | - | |
181 | Phosphorylation | PTISLKETIGKYSDD CEEEHHHHHHCCCCC | 33.18 | 29449344 | |
185 | Phosphorylation | LKETIGKYSDDHEMR HHHHHHCCCCCHHHH | 16.48 | 29449344 | |
186 | Phosphorylation | KETIGKYSDDHEMRN HHHHHCCCCCHHHHH | 39.79 | 23898821 | |
364 | Phosphorylation | IKDFPLETFHCPSPK ECCCCCCEECCCCCC | 26.77 | 30266825 | |
369 | Phosphorylation | LETFHCPSPKKMSFR CCEECCCCCCCCCCC | 55.54 | 30266825 | |
374 | Phosphorylation | CPSPKKMSFRKMDPS CCCCCCCCCCCCCCC | 30.68 | 24719451 | |
381 | Phosphorylation | SFRKMDPSCTIGFYC CCCCCCCCCEEEEEE | 21.45 | 21214269 | |
383 | Phosphorylation | RKMDPSCTIGFYCRN CCCCCCCEEEEEECC | 28.59 | - | |
387 | Phosphorylation | PSCTIGFYCRNVQDF CCCEEEEEECCHHHH | 5.81 | 21214269 | |
398 | Phosphorylation | VQDFKRASEEITKML HHHHHHHHHHHHHHH | 39.53 | 27251275 | |
403 | Ubiquitination | RASEEITKMLKFSSK HHHHHHHHHHHCCCC | 48.15 | - | |
413 | Phosphorylation | KFSSKEKYPLFTFVN HCCCCCCCCEEEEEC | 13.27 | 26074081 | |
417 | Phosphorylation | KEKYPLFTFVNGHSR CCCCCEEEEECCCCC | 34.06 | 26074081 | |
423 | Phosphorylation | FTFVNGHSRDYDFTS EEEECCCCCCCCCCC | 28.39 | 26074081 | |
426 | Phosphorylation | VNGHSRDYDFTSTTT ECCCCCCCCCCCCCC | 16.31 | 26074081 | |
429 | Phosphorylation | HSRDYDFTSTTTNEE CCCCCCCCCCCCCHH | 23.43 | 26074081 | |
430 | Phosphorylation | SRDYDFTSTTTNEED CCCCCCCCCCCCHHH | 24.61 | 26074081 | |
431 | Phosphorylation | RDYDFTSTTTNEEDL CCCCCCCCCCCHHHC | 34.28 | 26074081 | |
432 | Phosphorylation | DYDFTSTTTNEEDLF CCCCCCCCCCHHHCC | 27.65 | 26074081 | |
433 | Phosphorylation | YDFTSTTTNEEDLFS CCCCCCCCCHHHCCC | 40.50 | 26074081 | |
440 | Phosphorylation | TNEEDLFSEDEKKQL CCHHHCCCHHHHHHH | 51.97 | 28450419 | |
451 | Phosphorylation | KKQLKRFSTEEFVLL HHHHHCCCCCCEECC | 38.65 | 27273156 | |
452 | Phosphorylation | KQLKRFSTEEFVLL- HHHHCCCCCCEECC- | 36.50 | 22617229 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ATG4C_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ATG4C_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATG4C_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SPTC1_HUMAN | SPTLC1 | physical | 20562859 | |
PSMD2_HUMAN | PSMD2 | physical | 20562859 | |
PRS7_HUMAN | PSMC2 | physical | 20562859 | |
PRS4_HUMAN | PSMC1 | physical | 20562859 | |
UBP11_HUMAN | USP11 | physical | 20562859 | |
PRKDC_HUMAN | PRKDC | physical | 20562859 | |
PRS8_HUMAN | PSMC5 | physical | 20562859 | |
PRS6B_HUMAN | PSMC4 | physical | 20562859 | |
SMC1A_HUMAN | SMC1A | physical | 20562859 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. |